NCT05968521

Brief Summary

Heart problems are amongst the most common physical illnesses in children and young people (CYP). They can be present from birth or develop as CYP get older and are linked to increased physical and psychological difficulties overprotection from caregivers and healthcare providers and reduced quality of life. While adults are offered exercise classes and lifestyle advice after a heart problem, CYP with heart problems are not. Improving health behaviours in people with heart problems is vital, improves quality of life and reduces additional illnesses (i.e obesity, diabetes). Approximately 1 in 3 CYP with heart problems have anxiety and/or depression so it is also important to support their mental health. One way to do this is to develop and test the acceptability and feasibility of a trial of cardiac rehabilitation (CR) consisting of exercise with mental health support for CYP. The aim is to develop and test the feasibility and acceptability of a trial of a cardiac rehabilitation programme for CYP.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

March 4, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

March 7, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

May 9, 2023

Last Update Submit

March 6, 2024

Conditions

Keywords

Cardiac RehabilitationMetacognitive TherapyMental healthFeasibilityCongenital Heart Disease

Outcome Measures

Primary Outcomes (4)

  • Recruitment Rate (Feasibility Outcome)

    Feasibility will be assessed using recruitment rate (i.e., number of patients consented and randomized, number of patients declined the study).

    Date of Baseline Assessment to end of follow-up (24 week follow up)

  • Retention Rate (Feasibility Outcome)

    Feasibility will be assessed using retention rates (i.e., number of patients withdrawn from the study, lost to follow up)

    Date of Baseline Assessment to end of follow-up (24 week follow up)

  • Intervention Attendance (Feasibility Outcome)

    Feasibility will be assessed using participant attendance at intervention (i.e., number of sessions attended at the intervention).

    Date of Baseline Assessment to end of follow-up (24 week follow up)

  • Acceptability of the Intervention

    Acceptability of the intervention will be assessed in qualitative semi-structured interviews with children and young people, caregivers, and healthcare professionals, which will assess individuals views on the intervention, targets for improvement, and perceived acceptability of the components of the cardiac rehabilitation programme.

    Date of Baseline Assessment to end of follow-up (24 week follow up)

Secondary Outcomes (9)

  • Strength and Difficulties Questionnaire (SDQ)

    Baseline, 12 weeks (end of treatment), and 24 weeks (follow-up)

  • Paediatric Quality of Life (PedsQol)

    Baseline, 12 weeks (end of treatment), and 24 weeks (follow-up)

  • Six minute walk test (6MWT)

    Baseline, 12 weeks (end of treatment), and 24 weeks (follow-up)

  • Incremental Shuttle Walk Test (ISWT)

    Baseline, 12 weeks (end of treatment), and 24 weeks (follow-up)

  • Physical Activity Monitoring

    Baseline, 12 weeks (end of treatment), and 24 weeks (follow-up)

  • +4 more secondary outcomes

Study Arms (2)

Cardiac Rehabilitation (Intervention)

EXPERIMENTAL

Participants allocated to the intervention group will receive a cardiac rehabilitation (CR) programme which will involve education, exercise, and a psychological component.

Behavioral: Cardiac Rehabilitation (CR): Experimental

Treatment as usual (Control)

ACTIVE COMPARATOR

Participants allocated to the control group will receive treatment as usual.

Behavioral: Treatment as usual: Control

Interventions

CR will consist of six sessions lasting 90 minutes of a structured exercise programme, educational and lifestyle modules, and a psychological component. Sessions include group discussions, experiential learning and homework tasks that participants are asked to complete between sessions. Participants in this treatment arm will also receive routine clinical outpatient management alongside CR.

Cardiac Rehabilitation (Intervention)

Treatment as usual will include routine clinical outpatient management.

Treatment as usual (Control)

Eligibility Criteria

Age11 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Fluent in English
  • Consent to participate
  • Diagnosed with at least one of the following:
  • Congenital heart disease (all subtypes)
  • Cardiomyopathy
  • Cardiac arrhythmia
  • Heart failure
  • Post-cerebrovascular event
  • Post-heart valve repair/replacement

You may not qualify if:

  • Significant risk or safeguarding concerns (i.e., suicidal ideation)
  • Head injury/organic impairment
  • Significant social and/or communication difficulties

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manchester University NHS Foundation Trust

Manchester, M13 9WL, United Kingdom

RECRUITING

Related Publications (1)

  • Capobianco L, Hann M, McManus E, Peters S, Doherty PJ, Ciotti G, Murray J, Wells A. Cardiac rehabilitation for children and young people (CardioActive): protocol for a single-blind randomised feasibility and acceptability study of a centre-based cardiac rehabilitation programme versus usual care in 11-16 years with heart conditions. BMJ Open. 2024 Feb 24;14(2):e077958. doi: 10.1136/bmjopen-2023-077958.

MeSH Terms

Conditions

Heart Defects, CongenitalCardiomyopathiesHeart FailureHeart Valve DiseasesPsychological Well-Being

Interventions

Cardiac RehabilitationTherapeutics

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPersonal SatisfactionBehavior

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Lora Capobianco, PhD

    Greater Manchester Mental Health Foundation Trust

    PRINCIPAL INVESTIGATOR
  • Adrian Wells, PhD

    University of Manchester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinding of allocation will be maintained for the principal investigator's, statistician, and quantitative research assistant.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study is a single blind parallel randomised feasibility trial comparing a CR programme against usual care with 100 CYP (50 per arm) aged 11-16 diagnosed with a heart condition.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 9, 2023

First Posted

August 1, 2023

Study Start

March 4, 2024

Primary Completion

August 31, 2024

Study Completion

November 30, 2024

Last Updated

March 7, 2024

Record last verified: 2024-03

Locations